首页> 中文期刊>中国生化药物杂志 >基于新医改的药品定价机制改革初探

基于新医改的药品定价机制改革初探

     

摘要

New healthcare reform has been achieved remarkable effects and had a lot of acceptance by people at home and abroad. As the reason of the historical and medical system problem, high Medicine Price still exists in the most area of China. It is necessary to establish a reasonable mechanism of drugpricing and improve financial efficiencies of medical reform to guarantee the smooth and healthy development of healthcare reform.%新医改的推行成效显著,获得国内外各层次群体的认可。由于历史和机制问题,药价虚高仍大面积存在,制定完善的药品定价机制,提高医疗资金使用效率,有利于医改事业的顺利健康推行。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号